Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits.

Faulkner, Valwynne; Cox, Adrienne Adele; Goh, Shan; van Bohemen, Annelies; Gibson, Amanda J; Liebster, Oliver; Wren, Brendan W; Willcocks, Sam; Kendall, Sharon L; (2020) Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits. Frontiers in microbiology, 11. p. 619427. ISSN 1664-302X DOI: https://doi.org/10.3389/fmicb.2020.619427

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3389/fmicb.2020.619427

Abstract

Share

Download

Filename: Re-sensitization of iMycobacterium smegmatisi to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar